In this clip from my Forbes interview, I reflect on just some of the “home runs” over the years and highlight @EvidenceOpen, one of the most promising companies in the Breyer Capital healthcare portfolio which we invested in three years ago as part of the first outside capital. OpenEvidence is transforming the patient experience by taming the medical-information firehose. The company aggregates, synthesizes, and visualizes clinically relevant data in clear, accessible formats, empowering patients and clinicians to make more evidence-based decisions and deliver better care. It’s a pleasure and privilege to work with Daniel Nadler for the third time. We’ve been very early investors in several transformative AI healthcare companies including @arteraAI , @AtroposHealth , @Cleerlyhealth, @Iterative_Hlth, @LyraHealth , @SandboxAQ, and Soley Therapeutics, and continue to double down on the exceptional founders and teams driving the next generation of patient outcomes.